Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys
- 31 December 1983
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 34 (14), 1325-1331
- https://doi.org/10.1016/0024-3205(84)90003-1
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Effects of naloxone on the secretion of prolactin and corticosterone induced by 5-hydroxytryptophan and a serotonergic agonist, CPPLife Sciences, 1983
- 1-m-Chlorophenylpiperazine is an active metabolite common to the psychotropic drugs trazodone, etoperidone and mepiprazoleJournal of Pharmacy and Pharmacology, 1982
- Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodoneJournal of Pharmacy and Pharmacology, 1982
- Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretionEuropean Journal of Pharmacology, 1981
- (—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodoneJournal of Pharmacy and Pharmacology, 1981
- Disposition and pharmacological effects of m-Chlorophenylpiperazine in ratsNeuropharmacology, 1981
- Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in ratsNeurochemistry International, 1981
- 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazineJournal of Pharmacy and Pharmacology, 1980
- Effect of Serotonin-Releasing Drugs on Serum Corticosterone Concentration in RatsNeuroendocrinology, 1980
- Biogenic Amines and the States of SleepScience, 1969